118 related articles for article (PubMed ID: 10027514)
1. Effects of haloperidol treatment on prolactin response to D-fenfluramine challenge in acute schizophrenia.
Mohr P; Horácek J; Motlová L; Libiger J; Czobor P
Psychopharmacology (Berl); 1999 Jan; 141(3):322-5. PubMed ID: 10027514
[TBL] [Abstract][Full Text] [Related]
2. Prolactin response to D-fenfluramine challenge test as a predictor of treatment response to haloperidol in acute schizophrenia.
Mohr P; Horácek J; Motlová L; Libiger J; Czobor P
Schizophr Res; 1998 Feb; 30(1):91-9. PubMed ID: 9542792
[TBL] [Abstract][Full Text] [Related]
3. Risperidone is associated with blunting of D-fenfluramine evoked serotonergic responses in schizophrenia.
Jones H; Curtis VA; Wright PA; Lucey JV
Int Clin Psychopharmacol; 1998 Sep; 13(5):199-203. PubMed ID: 9817624
[TBL] [Abstract][Full Text] [Related]
4. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone.
Markianos M; Hatzimanolis J; Lykouras L
Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043
[TBL] [Abstract][Full Text] [Related]
6. Prolactin response to dl-fenfluramine challenge before and after treatment with paroxetine.
Dulchin MC; Oquendo MA; Malone KM; Ellis SP; Li S; Mann JJ
Neuropsychopharmacology; 2001 Sep; 25(3):395-401. PubMed ID: 11522467
[TBL] [Abstract][Full Text] [Related]
7. Prolactin response to low-dose haloperidol challenge in schizophrenic, non-schizophrenic psychotic, and control subjects.
Copolov DL; Keks NA; Kulkarni J; Singh BS; McKenzie D; McGorry P; Hill C
Psychoneuroendocrinology; 1990; 15(3):225-31. PubMed ID: 2255750
[TBL] [Abstract][Full Text] [Related]
8. Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement.
Curtis VA; Wright P; Reveley A; Kerwin R; Lucey JV
Br J Psychiatry; 1995 May; 166(5):642-6. PubMed ID: 7620750
[TBL] [Abstract][Full Text] [Related]
9. Serotonin transporter promoter polymorphism is associated with attenuated prolactin response to fenfluramine.
Reist C; Mazzanti C; Vu R; Tran D; Goldman D
Am J Med Genet; 2001 May; 105(4):363-8. PubMed ID: 11378851
[TBL] [Abstract][Full Text] [Related]
10. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
Cleare AJ; Murray RM; O'Keane V
Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879
[TBL] [Abstract][Full Text] [Related]
11. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
[TBL] [Abstract][Full Text] [Related]
13. Prolactin response to d-fenfluramine in combat-related post-traumatic stress disorder.
Schweitzer I; Morris P; Hopwood M; Maguire K; Norman T
Int J Neuropsychopharmacol; 2004 Sep; 7(3):291-8. PubMed ID: 15122972
[TBL] [Abstract][Full Text] [Related]
14. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine.
Markianos M; Hatzimanolis J; Lykouras L; Christodoulou GN
Schizophr Res; 2002 Jul; 56(1-2):11-7. PubMed ID: 12084414
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
Young AH; Rue J; Odontiadis J; Cowen PJ
Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
[TBL] [Abstract][Full Text] [Related]
16. Prolactin and cortisol responses to fenfluramine challenge in mania.
Yatham LN
Biol Psychiatry; 1996 Feb; 39(4):285-8. PubMed ID: 8645775
[TBL] [Abstract][Full Text] [Related]
17. Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors.
Kavoussi RJ; Hauger RL; Coccaro EF
Biol Psychiatry; 1999 Feb; 45(3):295-9. PubMed ID: 10023505
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms.
Jones H; Curtis VA; Wright P; Lucey JV
Am J Psychiatry; 1998 Jun; 155(6):838-40. PubMed ID: 9619161
[TBL] [Abstract][Full Text] [Related]
19. Prolactin response to bromperidol treatment in schizophrenic patients.
Yasui N; Kondo T; Otani K; Ishida M; Mihara K; Suzuki A; Kaneko S; Inoue Y
Pharmacol Toxicol; 1998 Mar; 82(3):153-6. PubMed ID: 9553995
[TBL] [Abstract][Full Text] [Related]
20. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
